Publication of the human genome SNP map is an early benchmark in efforts to increase the efficiency of drug development and improve the provision of medicine.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Shrunken methodology to genome-wide SNPs selection and construction of SNPs networks
BMC Systems Biology Open Access 13 September 2010
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
© Bob Crimi
References
The International SNP Map Working Group. Nature 409, 928–933 (2001).
Lazarou, J., Pomeranz, B.H. & Corey, P.N. JAMA 279, 1200–1205 (1998).
Evans, W.E. & Relling, M.V. Science 286, 487–491 (1999).
Yates, C.R. et al. Ann. Intern. Med. 126, 608–614 (1997).
Krynetski, E.Y. & Evans, W.E. Pharm. Res. 16, 342–349 (1999).
International Human Genome Sequencing Consortium. Nature 409, 860–921 (2001).
Nickerson, D.A. et al. Nat. Genet. 19, 233–240 (1998).
Levine, T.B. et al. Circulation 101, 758–764 (2000).
Bittar, N. Clin. Ther. 19, 954–962 (1997).
FDA Talk Paper. Rezulin to be withdrawn from the market. (FDA, Washington, DC, March 21, 2000).
Drysdale, C.M. et al. Proc. Natl. Acad. Sci. USA 97, 10483–10488 (2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rothberg, B. Mapping a role for SNPs in drug development. Nat Biotechnol 19, 209–211 (2001). https://doi.org/10.1038/85631
Issue Date:
DOI: https://doi.org/10.1038/85631
This article is cited by
-
Shrunken methodology to genome-wide SNPs selection and construction of SNPs networks
BMC Systems Biology (2010)
